Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accrual, acknowledging, adjuvant, aforementioned, antidilutive, antiepileptic, APIC, apparent, atonic, behavior, behavioral, Belgian, British, callosotomy, Century, childhood, clarity, clause, cliff, dedicated, description, dietary, durable, echocardiogram, ESPP, exceeded, exceeding, feasibility, Felbamate, focal, frame, herewith, holdback, hyperactivity, hypothetical, immigration, impending, inflow, internationally, Lamotrigine, LGS, lien, Luye, maximal, mentioned, merged, michael, modestly, modification, motor, multidrug, myoclonic, neurobehavioral, noncash, nonpharmacologic, nonstop, nonvested, Notwithstanding, outflow, Pantheon, passage, path, permanent, presidential, provisional, referendum, refractory, regime, repealed, replicate, reset, RMP, Rufinamide, shareholder, smith, spur, stream, Subtopic, thickening, tonic, Topiramate, unclear, uncontrolled, undiscounted, unimportant, USPTO, vacated, VNS, worth
Removed:
accommodated, accrue, adjust, administering, aerosolized, agonist, anxiety, article, Arzneimittel, autoinjector, Becton, beneath, Bioject, breakage, bronchia, bulk, cancelled, cap, capitalize, capitalized, carved, casing, certainty, China, chlorpromazine, closed, Clozaril, cluster, collection, commitment, comparing, concentration, consolidation, covenant, Cynthia, damping, decade, dependable, derecognized, derivative, Desitin, Dickinson, discreet, easier, Elan, eleven, enclosing, engineering, entry, exclude, expanding, explained, extend, extinguished, FDASIA, fear, fifteen, filled, firing, functional, gas, haloperidol, headache, hormone, India, inert, injecting, injector, inpatient, instance, insulin, internally, invoice, irrevocable, latch, leased, legally, lender, lithium, majeure, Mallinckrodt, manipulate, medium, migraine, mL, monotherapy, mood, Mumford, Munnerstadt, mutually, narrative, needle, needlestick, Owen, paper, partially, pen, perpetual, pledged, polytherapy, potent, practicing, preclude, predecessor, prepay, proceed, procurement, propensity, Psychiatry, PTO, publicized, Purdue, purged, remained, rental, repay, reserve, residing, revision, Robinson, run, runway, Russia, sensitivity, shock, societal, sourcing, stabilizer, structure, subcutaneously, sublicensable, sublingual, supported, syringe, technique, traditional, transdermal, transportation, undergone, version, wave, Weston, workforce, Ypsomed
Filing tables
Filing exhibits
Related press release
ZGNX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 Nos. 333-185900, 333-185901, 333-192109, 333-199957 and 333-211265) of Zogenix, Inc.,
(2) Registration Statement (Form S-8 No. 333-170875) pertaining to the 2006 Equity Incentive Plan, 2010 Equity Incentive Award Plan, and 2010 Employee Stock Purchase Plan of Zogenix, Inc.,
(3) Registration Statement (Form S-8 No. 333-181543) pertaining to the 2010 Equity Incentive Award Plan, as amended of Zogenix, Inc., and
(4) Registration Statement (Form S-8 No. 333-197998) pertaining to the Employment Inducement Equity Incentive Award Plan of Zogenix, Inc.;
of our reports dated March 9, 2017, with respect to the consolidated financial statements of Zogenix, Inc. and the effectiveness of internal control over financial reporting of Zogenix, Inc. and to the reference to our firm under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in this Annual Report (Form 10-K) of Zogenix, Inc. for the year ended December 31, 2016.
/s/ Ernst & Young LLP
San Diego, California
March 9, 2017